Analysis of an adenine nucleotide-containing metabolite of clodronate using ion pair high-performance liquid chromatography-electrospray ionisation mass spectrometry

被引:35
作者
Mönkkönen, H
Moilanen, P
Mönkkönen, J
Frith, JC
Rogers, MJ
Auriola, S
机构
[1] Univ Kuopio, Dept Pharmaceut, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
[3] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2000年 / 738卷 / 02期
关键词
clodronate;
D O I
10.1016/S0378-4347(99)00559-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Clodronate belongs to the family of bisphosphonates, which are synthetic analogues of pyrophosphate. Bisphosphonates are widely used in the treatment of metabolic bone diseases. Some bisphosphonates, including clodronate, can be metabolized in cells into non-hydrolysable nucleotide analogues. In this paper. we describe a new method for extraction and quantitation of the clodronate metabolite in cell lysates by using ion-pairing HPLC method that is compatible with negative ion electrospray ionization mass spectrometry (ESI-MS). The method was used for detection of the metabolite of clodronate in extracts from RAW 264 macrophage cells after treatment with clodronate. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 13 条
[1]  
AU JLS, 1989, CLIN CHEM, V35, P48
[2]   Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry [J].
Auriola, S ;
Frith, J ;
Rogers, MJ ;
Koivuniemi, A ;
Mönkkönen, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2) :187-195
[3]   BISPHOSPHONATES - PHARMACOLOGY AND USE IN THE TREATMENT OF TUMOR-INDUCED HYPERCALCEMIC AND METASTATIC BONE-DISEASE [J].
FLEISCH, H .
DRUGS, 1991, 42 (06) :919-944
[4]   Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta,gamma-dichloromethylene) triphosphate, by mammalian cells in vitro [J].
Frith, JC ;
Monkkonen, J ;
Blackburn, GM ;
Russell, RGG ;
Rogers, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (09) :1358-1367
[5]   REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF PURINE COMPOUNDS FOR INVESTIGATION OF BIOMEDICAL PROBLEMS - APPLICATION TO DIFFERENT TISSUES AND BODY-FLUIDS [J].
GRUNE, T ;
SIEMS, WG .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 618 (1-2) :15-40
[6]   Contrasting effects of alendronate and clodronate on RAW 264 macrophages:: the role of a bisphosphonate metabolite [J].
Makkonen, N ;
Salminen, A ;
Rogers, MJ ;
Frith, JC ;
Urtti, A ;
Azhayeva, E ;
Mönkkönen, J .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 8 (02) :109-118
[7]   GROWTH-INHIBITION OF MACROPHAGE-LIKE AND OTHER CELL-TYPES BY LIPOSOME-ENCAPSULATED, CALCIUM-BOUND, AND FREE BISPHOSPHONATES IN-VITRO [J].
MONKKONEN, J ;
TASKINEN, M ;
AURIOLA, SOK ;
URTTI, A .
JOURNAL OF DRUG TARGETING, 1994, 2 (04) :299-308
[8]   LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY - GENERAL-PRINCIPLES AND INSTRUMENTATION [J].
NIESSEN, WMA ;
TINKE, AP .
JOURNAL OF CHROMATOGRAPHY A, 1995, 703 (1-2) :37-57
[9]   CYTOTOXICITY OF DICHLOROMETHANE DIPHOSPHONATE AND OF 1-HYDROXYETHANE-1,1-DIPHOSPHONATE IN THE AMEBAS OF THE SLIME-MOLD DICTYOSTELIUM-DISCOIDEUM - A P-31 NMR-STUDY [J].
PELORGEAS, S ;
MARTIN, JB ;
SATRE, M .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2157-2163
[10]   Molecular mechanisms of action of bisphosphonates [J].
Rogers, MJ ;
Frith, JC ;
Luckman, SP ;
Coxon, FP ;
Benford, HL ;
Mönkkönen, J ;
Auriola, S ;
Chilton, KM ;
Russell, RGG .
BONE, 1999, 24 (05) :73S-79S